We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

148 hedge funds and large institutions have $1.32B invested in Acorda Therapeutics in 2013 Q2 according to their latest regulatory filings, with 148 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

475% more call options, than puts

Call options by funds: $14.7M | Put options by funds: $2.56M

Holders
148
Holders Change
+148
Holders Change %
–
% of All Funds
4.83%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
148
Increased
–
Reduced
–
Closed
–
Calls
$14.7M
Puts
$2.56M
Net Calls
+$12.2M
Net Calls Change
+$12.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MOACM
76
Mutual of America Capital Management
New York
$1.17M +$1.22M +296 New
Swiss National Bank
77
Swiss National Bank
Switzerland
$1.16M +$1.21M +293 New
MLICM
78
Metropolitan Life Insurance Company (MetLife)
New York
$1.07M +$1.11M +270 New
GI
79
GLG Inc
New York
$1.06M +$1.1M +267 New
CCI
80
Columbus Circle Investors
$1.06M +$1.1M +267 New
Manulife (Manufacturers Life Insurance)
81
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.05M +$1.1M +266 New
MVP
82
Missouri Valley Partners
Missouri
$1.04M +$1.08M +263 New
AIG
83
American International Group
New York
$1.03M +$1.07M +261 New
CS
84
Credit Suisse
Switzerland
$1.02M +$1.06M +258 New
Axa
85
Axa
France
$1.02M +$1.06M +258 New
New York State Teachers Retirement System (NYSTRS)
86
New York State Teachers Retirement System (NYSTRS)
New York
$1.01M +$1.05M +256 New
AQR Capital Management
87
AQR Capital Management
Connecticut
$993K +$1.03M +251 New
EI
88
EAM Investors
California
$915K +$951K +231 New
PA
89
Profund Advisors
Maryland
$896K +$930K +226 New
TC
90
TFS Capital
Pennsylvania
$843K +$877K +213 New
PAM
91
Paradigm Asset Management
New York
$833K +$865K +210 New
N
92
Nuveen
North Carolina
$832K +$865K +210 New
CAM
93
Capstone Asset Management
Texas
$820K +$852K +207 New
RFC
94
Russell Frank Company
Washington
$789K +$819K +199 New
SCM
95
Stevens Capital Management
Pennsylvania
$786K +$819K +199 New
VRS
96
Virginia Retirement Systems
Virginia
$739K +$770K +187 New
U
97
UBS
Switzerland
$719K +$749K +182 New
BlackRock
98
BlackRock
New York
$714K +$741K +180 New
Susquehanna International Group
99
Susquehanna International Group
Pennsylvania
$594K +$618K +150 New
KeyBank National Association
100
KeyBank National Association
Ohio
$588K +$609K +148 New
2 3
4
5 6

ACOR Hedge Fund Activity: Q2 2013 in Review

148 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2013, worth a combined $1.32B.

Buyers outnumbered sellers: 148 funds opened new ACOR positions and 0 closed out — a net gain of 148 holders — while 0 added to existing stakes and 0 trimmed.

  • 148 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $1.32B of Acorda Therapeutics stock for Q2 2013.
  • 148 funds opened new Acorda Therapeutics positions in Q2 2013 and 0 closed out, a net change of +148 holders.

Based on aggregated 13F filings for Q2 2013.